Evaluation of the Japanese Version of the Cancer Survivors' Unmet Needs Scale
Evaluation of the Japanese Version of the Cancer Survivors' Unmet Needs Scale
复制标题
DOI：
10.4103/apjon.apjon_49_19
复制
发表时间：
2020-04-01
影响因子：
1.8
通讯作者：
Hayashida, Tetsu
中科院分区：
文献类型：
--
作者：
Komatsu, Hiroko;Yagasaki, Kaori;Hayashida, Tetsu
目的：本研究旨在评估日本版癌症幸存者未满足需求量表（CaSUN-J）在日本癌症幸存者中的心理测量特征。方法：采用标准化翻译方法编制CaSUN-J。内容效度由专家小组进行评估，并以10名癌症患者作为方便样本进行了试点测试。共有183名日本癌症幸存者完成了CaSUN-J。采用Cronbach’s alpha检验量表的内部一致性。结构效度分析使用与身体效果，生活质量（QoL）和年龄的相关性。为了评估CaSUN-J的因子效度，进行了验证性因子分析（CFA）。结果：CaSUN-J具有良好的可读性和较高的内容效度，可作为日本癌症幸存者的评估工具。所有的Cronbach’s alpha系数均高于>= 0.70的最低可接受标准。对于结构效度，较高的身体效果评分、较差的生活质量评分和较年轻的患者与较高的需求水平显著正相关。CFA表明，CaSUN-J的五因子结构与数据拟合良好。结论：CaSUN-J可以作为评估日本癌症幸存者未满足需求的有效和可靠的工具。
Objective: This study aimed to evaluate the psychometric properties of the Japanese version of the Cancer Survivors' Unmet Needs (CaSUN-J) scale among cancer survivors in Japan. Methods: The CaSUN-J was developed using standardized translation methodology. Content validity was evaluated by a group of experts, and a pilot test was conducted with a convenience sample of 10 cancer patients. A total of 183 Japanese cancer survivors completed the CaSUN-J. The internal consistency of the scale was examined with Cronbach's alpha. Construct validity was analyzed using correlations with the physical effects, quality of life (QoL), and age. To assess the factorial validity of the CaSUN-J, confirmatory factor analysis (CFA) was performed. Results: The CaSUN-J indicated good readability and high content validity for use as an assessment tool among Japanese cancer survivors. All Cronbach's alpha coefficients were above the minimum acceptable criterion of >= 0.70. For construct validity, higher physical effect scores, as well as poorer QoL scores and younger patients, were significantly positively associated with higher levels of needs. CFA indicated that the five-factor structure of the CaSUN-J was a good fit to the data. Conclusions: The CaSUN-J can serve as a valid and reliable tool to evaluate unmet needs among Japanese cancer survivors.